Opportunities in The (Overpriced) Japan Pharma Sector
As a defensive sector, Japan’s pharmaceutical sector has had an up-and-down time of it during the Abe era. In the early days of Abenomics, the...
267 Views
Ono FY17 Earnings - First Glance
Ono Pharmaceutical Co Ltd (4528 JP) reported FY17 results on May 10, 2018 Opdivo led FY17 topline growth and gross margins expansion in line with...
235 Views
Ono’s Stock Price Decline on Merck’s KN-189 Success
On April 16, 2018, the topline data for Ono Pharmaceutical Co Ltd (4528 JP) Opdivo and Merck & Co. Inc. (MRK US) Keytruda, both as a...
221 Views
Ono’s Stock Price Decline on Merck’s KN-042 Success
Merck & Co. (NYSE: MRK), on April 09, 2018, announced Keytruda’s (pembrolizumab) success in improving overall survival (OS) as 1L treatment in...
202 Views
Cyberdyne (7779) - Is This the Death-Knell for Short Sell Reports on Japanese Stocks?
Shares in Cyberdyne (7779 JP) have surged following the news that it has gained approval in the US for its "Medical HAL" exoskeleton suit to be...
562 Views